ASP-1929 Photoimmunotherapy

ASP-1929 · Rakuten Medical, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ASP-1929 Photoimmunotherapy, covering 2024-08-16 to 2025-06-19. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors [Phase 1, Phase 2]

See pricing